Live Rate
| Open | |
|---|---|
| High | |
| Low | |
| Prev. Close | |
| Lower circuit | |
| Upper circuit | |
| 52w High | |
| 52w Low | |
| P/E Ratio |
Star Imaging & Path Lab Listing Price
| Exchange | Listing Price | Gain/Loss | % |
|---|---|---|---|
| BSE | ₹142.00 | ₹0.00 | 0.00% |
Star Imaging & Path Lab Subscription
Last updated on 12-Aug-2025 17:06:02
| Category | Offered | Applied | Times |
|---|---|---|---|
| QIBs | 871000 | 11188000 | 12.85 |
| HNIs | 657000 | 2878000 | 4.38 |
| bHNI | 438000 | 2242000 | 5.12 |
| sHNI | 219000 | 636000 | 2.9 |
| Individual | 1528000 | 3532000 | 2.31 |
| Employee | 52000 | 16000 | 0.31 |
| Total | 3108000 | 17614000 | 5.67 |
Application-Wise Breakup  | |||
|---|---|---|---|
| Category | Reserved | Applied | Times |
| HNIs (10L+) | 146 | 257 | 1.76 |
| HNIs (3-10L) | 73 | 192 | 2.63 |
| Individual | 764 | 1766 | 2.31 |
| QIB Interest Cost Per Share (7 Days) | |||||
|---|---|---|---|---|---|
| @7% ₹2.4 | @8% ₹2.8 | @9% ₹3.1 | @10% ₹3.5 | @11% ₹3.8 | @12% ₹4.2 |
Star Imaging & Path Lab About
| Category | Lot(s) | Qty | Amount | Reserved |
|---|---|---|---|---|
| bHNI | 8 | 8000 | 1136000 | 146 |
IPO Reservation
| Investor Category | Shares Offered | No. of Shares |
|---|---|---|
| Individual | 31.23% | 1528000 |
| BHNI | 8.95% | 438000 |
| SHNI | 4.48% | 219000 |
| QIB | 17.80% | 871000 |
| Anchor | 26.66% | 1304000 |
| Employees | 1.06% | 52000 |
| Market Maker | 9.81% | 480000 |
| Total | 100.00% | 4892000 |
IPO Details
| Total Issue Size | 48,92,000 shares (aggregating up to ₹69.46 Cr) |
| Fresh Issue | 39,20,000 shares (aggregating up to ₹55.66 Cr) |
| Offer For Sale | 9,72,000 shares (aggregating up to ₹13.80 Cr) |
| Issue Type | Bookbuilding IPO |
| Listing At | BSE SME |
| Share Holding Pre Issue | 1,35,00,000 shares |
| Share Holding Post Issue | 1,74,20,000 shares |
| Reserved for Market Maker | 4,80,000 shares (aggregating up to ₹6.81 Cr) |
| Market Maker | Share India Securities Limited |
Key Performance Indicator (KPI)
| KPI | Mar-25 | Mar-24 | Mar-23 |
|---|---|---|---|
| ROCE | 29.83% | 29.54% | 5.74% |
| EPS (basic) | 11.79 | 9.14 | 0.42 |
| P/E Pre IPO | 12.01 | ||
| P/E Post IPO | 15.5 |
Company Financial In Crore
| Period Ended | Mar-25 | Mar-24 | Mar-23 |
|---|---|---|---|
| Assets | 98.2 | 81.6 | 61.2 |
| Total Income | 83.8 | 80.0 | 58.7 |
| Profit After Tax | 16.0 | 12.5 | 0.6 |
| EBITDA | 28.6 | 22.3 | 5.8 |
| Net Worth | 47.2 | 31.4 | 18.9 |
| Reserves and Surplus | 33.7 | 29.9 | 17.4 |
| Total Borrowing | 32.7 | 30.6 | 26.6 |
About Company
Incorporation Year: 2004
Industry: Healthcare & Diagnostics
Core Business:
Star Imaging and Path Lab Limited offers comprehensive diagnostic services, including both imaging and laboratory testing, to individuals and healthcare institutions.
Key Offerings
1. Imaging Services:
- Digital X-ray
- Mammography
- CT Scans
- MRI
- 4D & 5D Ultrasounds
2. Pathology Services:
- Haematology
- Microbiology
- PCR (Polymerase Chain Reaction)
- Histopathology
3. Diagnostic Testing:
- Routine Testing
- Special Testing
Strengths
- Equipped with advanced diagnostic technology
- Team of experienced medical professionals
- Focus on accurate and timely reporting
- Presence across multiple regions in India
Workforce
As of September 30, 2024, the company employs 209 full-time staff, including executive directors.
Strength
Comprehensive Diagnostic Services : Offers both pathology and radiology services under one roof, providing a complete diagnostic solution.
Established Market Presence : Proven track record with an established presence in the healthcare diagnostics sector.
Experienced Leadership Team : Led by a dedicated management team with strong industry experience and domain knowledge.
Weakness
Ongoing Legal Proceedings : The Company, Promoter, and Directors are involved in certain legal cases, and any unfavorable outcome may impact the business and financial health.
Non-Filing of Consolidated Financials : There have been past instances of not filing consolidated financial statements with the RoC, which could lead to regulatory concerns.
CSR Non-Compliance : The Company has not met its CSR obligations for FY 2021–22 to FY 2023–24, which may result in penalties for the Company and its Directors.
Star Imaging & Path Lab Latest Announcements
| Date | Subject | Attachment Text |
|---|
Star Imaging & Path Lab Financial Results
Star Imaging & Path Lab Lead Manager(s)
Star Imaging & Path Lab Address
4B/4,
Tilak Nagar, Near Sant Pura,
Tilak Nagar West Delhi, New Delhi- 110018
New Delhi, New Delhi, 110018
Phone: +91 9990019189
Email: cs@starimaging.in
Website: https://www.starimaging.in/